Print

Genelabs Technologies, Inc. (GNLB) Announces Presentation Of Data On Non-Nucleoside HCV Polymerase Inhibitor at the 15th International Symposium on Hepatitis C Virus and Related Viruses  
10/9/2008 11:01:17 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB) announced that three presentations were made at the 15th International Symposium on Hepatitis C Virus and Related Viruses, each on a non-nucleoside hepatitis C virus (HCV) polymerase inhibitor discovered by Genelabs.
//-->